dsip-safety-data DSIP DSIP – Research Peptide |

10.1038/s41598-017-15028-x 106

Key gaps include: No large-scale randomised controlled trials in humans the evidence basis for clinical use is extrapolated from animal data and small pilot studies No long-term safety data effects beyond 1216 weeks are not well characterised Variable results in human sleep trials some early human studies showed modest or inconsistent effects on sleep architecture compared to animal data, suggesting the translation may not be linear No FDA approval DSIP is not approved for any therapeutic use in the United States Stability concerns DSIP degrades relatively quickly in circulation

How Epithalon (10mg) Supports Research In laboratory settings, Epithalon is used as a research tool peptide in studies that investigate cellular aging mechanisms and telomere-associated biology

It does not, and the FDA's reasoning here is worth taking seriously

About the Author Maryke Louw is a chartered physiotherapist with more than 20 years' experience and a Masters Degree in Sports Injury Management

That is the main thing I look for when ordering peptides. Daniel Reed Dihexa High-Affinity Hepatocyte Growth Factor Modulator Dihexa is a small-molecule peptide analogue investigated for its high-affinity interaction with the hepatocyte growth factor (HGF) and c-Met receptor system